Cardiex Ltd
ASX:CDX

Watchlist Manager
Cardiex Ltd Logo
Cardiex Ltd
ASX:CDX
Watchlist
Price: 0.034 AUD -5.56% Market Closed
Market Cap: 18.7m AUD

Cardiex Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cardiex Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Cardiex Ltd
ASX:CDX
EPS (Diluted)
AU$0
CAGR 3-Years
26%
CAGR 5-Years
4%
CAGR 10-Years
-15%
Somnomed Ltd
ASX:SOM
EPS (Diluted)
AU$0
CAGR 3-Years
21%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
C
Cyclopharm Ltd
ASX:CYC
EPS (Diluted)
AU$0
CAGR 3-Years
-44%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Cochlear Ltd
ASX:COH
EPS (Diluted)
AU$5
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
9%
Austco Healthcare Ltd
ASX:AHC
EPS (Diluted)
AU$0
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
N/A
EMvision Medical Devices Ltd
ASX:EMV
EPS (Diluted)
AU$0
CAGR 3-Years
-11%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
No Stocks Found

Cardiex Ltd
Glance View

Market Cap
18.7m AUD
Industry
Health Care

CardieX Ltd. is engaged in the designing, manufacturing, and marketing of medical devices for use in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm is focused on designing, manufacturing and marketing medical devices for use in cardiovascular health management. The company operates through its subsidiaries, including ATCOR and CONNEQT. The firm's ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the ATCOR.X brand, the Company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The firm's digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients' health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness and wellness parameters.

CDX Intrinsic Value
Not Available

See Also

What is Cardiex Ltd's EPS (Diluted)?
EPS (Diluted)
-0 AUD

Based on the financial report for Jun 30, 2025, Cardiex Ltd's EPS (Diluted) amounts to -0 AUD.

What is Cardiex Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-15%

Over the last year, the EPS (Diluted) growth was -33%. The average annual EPS (Diluted) growth rates for Cardiex Ltd have been 26% over the past three years , 4% over the past five years , and -15% over the past ten years .

Back to Top